{"id":63056,"date":"2026-05-05T10:02:26","date_gmt":"2026-05-05T08:02:26","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/rimsys-launches-the-regulatory-execution-engine-for-medtech\/"},"modified":"2026-05-05T10:02:26","modified_gmt":"2026-05-05T08:02:26","slug":"rimsys-launches-the-regulatory-execution-engine-for-medtech","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/rimsys-launches-the-regulatory-execution-engine-for-medtech\/","title":{"rendered":"Rimsys Launches the Regulatory Execution Engine for MedTech"},"content":{"rendered":"
\n

\nSpring 2026 embeds submission authoring, AI-powered regulatory monitoring, and configurable impact workflows inside a single RIM platform, the first step toward Rimsys\u2019 AI vision for global regulatory operations.<\/i><\/p>\n

<\/a>
<\/a><\/p>\n

PITTSBURGH–(BUSINESS WIRE)–Regulatory Information Management (RIM) software was built to store records. That foundation has served its purpose and reached its limit. Today, Rimsys<\/a> announces the Spring 2026 release: a platform designed not to hold regulatory data, but to execute on it.<\/p>\n

\nSubmission volumes are growing. Markets are multiplying. Regulatory change is accelerating. Spring 2026 gives regulatory teams the tools to keep pace: embedded authoring, reusable submission content, configurable impact workflows, and AI-powered intelligence, all inside a single platform.<\/p>\n

\n“Our vision for Rimsys is a platform that makes regulatory expertise go further, companies move faster, and products reach more markets than any team could accomplish alone. Spring 2026 is another meaningful step toward that vision. We are embedding the tools and intelligence that allow regulatory affairs professionals to operate at a different level, doing more strategic work, entering markets faster, and staying ahead of regulatory change rather than reacting to it. What we are building next makes this release the starting line.” <\/i>\u2013 James Gianoutsos, CEO<\/p>\n

\nWhat Spring 2026 Delivers<\/b><\/p>\n

\nA <\/b>brand new website<\/b><\/a> that provides in-depth information about the Rimsys offering and the benefits to MedTech manufacturers, including details on these new products:<\/b><\/p>\n

\nIntelligence: AI-Powered Regulatory Monitoring<\/b><\/p>\n

\nRimsys Intelligence<\/a> provides access to regulations, guidance documents, safety alerts, and legislation across more than 90 countries. AI triage and prioritization surface the updates most relevant to each customer\u2019s specific products and markets, eliminating hours of manual surveillance and putting the right information in front of the right people.<\/p>\n

\nWhen a change requires action, teams can move directly from regulatory signal to impact assessment without a manual handoff. Intelligence represents Rimsys\u2019 first production deployment of context-aware AI operating across a customer\u2019s live regulatory data, a foundation that will expand significantly in future releases.<\/p>\n

\nAdvanced Submissions: A Unified Submission Execution Workflow<\/b><\/p>\n

\nAdvanced Submissions<\/a> consolidates everything required to create, manage, and publish a regulatory submission into a single workflow inside Rimsys, eliminating the disconnected tools, manual reformatting, and version fragmentation that have defined submission work for too long. Three capabilities anchor it:<\/p>\n

\nRimsys Editor<\/b><\/p>\n

\nThe Rimsys Editor is the cornerstone of Advanced Submissions and the most significant capability in this release. It brings word-compatible authoring and editing natively inside Rimsys, fully compatible with Microsoft Word\u00ae<\/sup>, allowing regulatory teams to create, co-author, review, and publish submission content without leaving the platform for the first time.<\/p>\n

\nThe Editor supports real-time co-authoring, tracked changes and redlining, rich content including tables and images, document comparison, and PDF publishing with standardized headers, footers, and company branding applied automatically. AI-assisted authoring is available as a configurable option, enabling teams to summarize, refine, expand, and translate content within their workflow. Rimsys AI<\/a> is human-in-the-loop by design.<\/p>\n

\nUniversal Submissions<\/b><\/p>\n

\nUniversal Submissions enables teams to build from a single universal template (an IMDRF Technical Document) with content automatically mapped into market-specific templates. One master structure, many markets, without rebuilding from scratch.<\/p>\n

\nReusable Submissions<\/b><\/p>\n

\nReusable Submissions takes a completed submission from one market and uses it as the starting point for a new one. The system automatically maps content into the target market\u2019s template, carrying applicable sections forward reducing the content creation time up to 90% and compressing the time required to enter each additional market.<\/p>\n

\nConfigurable Impact Surveys: Governed Change Assessment at Scale<\/b><\/p>\n

\nImpact Surveys<\/a> are now fully configurable. Templates can be defined for specific change event types, tied to countries or registrations, and triggered automatically from Rimsys Intelligence findings replacing ad hoc assessments with repeatable, governed workflows. This integration creates a direct line from change event to regulatory scope, with results tracked in a single audit-ready trail.<\/p>\n

\nA Platform Built for What\u2019s Next<\/b><\/p>\n

\nSpring 2026 establishes more than a set of new capabilities. It establishes the execution infrastructure, structured data model, and embedded AI foundation<\/a> on which Rimsys\u2019 longer-term vision is being built.<\/p>\n

\nThat vision: a world where regulatory experts are amplified by intelligence, not constrained by information. Where the knowledge required to enter a new market, interpret a regulatory change, or scope a submission is instantly available to every member of the team. Where regulatory operations scale not by spreading experts thin, but by giving them tools that multiply their impact.<\/p>\n

\nSpring is the first production step in that direction. Every submission authored inside the platform, every intelligence signal triaged by AI, and every impact assessment connected to structured regulatory data deepens the foundation. Future releases will build on it directly, expanding AI capabilities, automating more of the regulatory workflow, and ultimately enabling teams to do work that today requires external expertise to be done inside Rimsys.<\/p>\n

\nRegulatory Execution as a Business Lever<\/b><\/p>\n

\nSpring 2026 is built to move metrics that matter: reduced submission cycle time variance, improved approval predictability, lower marginal effort per market, and increased team capacity without proportional headcount growth. For executive leadership, earlier approvals translate directly into faster market access and accelerated revenue recognition.<\/p>\n

\nAvailability<\/b><\/p>\n

\nSpring 2026 is now Generally Available. Existing customers on the Organizer product will retain access to their current experience.<\/p>\n

\nTo learn more about the Spring 2026 release and how Rimsys can accelerate your regulatory operations, visit rimsys.io or contact your Rimsys representative.<\/p>\n

\nAbout Rimsys<\/b><\/p>\n

\nRimsys is the heart of regulatory operations for the medical device industry and the platform at the center of an AI-driven transformation in how regulated products reach global markets. A living, connected regulatory platform, Rimsys keeps regulatory intelligence, product data, approvals, and change management continuously connected, enabling organizations to expand into global markets with speed, precision, and confidence. Enterprise-ready yet intuitive to use, Rimsys is trusted by 6 of the top 12 global MedTech manufacturers to accelerate time to market and scale regulatory operations worldwide. To learn more, visit rimsys.io<\/b>.<\/p>\n

\nCopyright \u00a9 2026 Rimsys, Inc. All rights reserved.<\/i><\/p>\n

Contacts<\/b> <\/p>\n

\nMedia Contact<\/b>
letschat@rimsys.io<\/a>
rimsys.io<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Spring 2026 embeds submission authoring, AI-powered regulatory monitoring, and configurable impact workflows inside a single RIM platform, the first step toward Rimsys\u2019 AI vision for global regulatory operations. PITTSBURGH–(BUSINESS WIRE)–Regulatory Information Management (RIM) software was built to store records. That foundation has served its purpose and reached its limit. Today, Rimsys announces the Spring 2026 … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-63056","6":"format-standard","7":"category-industry"},"yoast_head":"\nRimsys Launches the Regulatory Execution Engine for MedTech - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/rimsys-launches-the-regulatory-execution-engine-for-medtech\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Rimsys Launches the Regulatory Execution Engine for MedTech - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Spring 2026 embeds submission authoring, AI-powered regulatory monitoring, and configurable impact workflows inside a single RIM platform, the first step toward Rimsys\u2019 AI vision for global regulatory operations. PITTSBURGH–(BUSINESS WIRE)–Regulatory Information Management (RIM) software was built to store records. That foundation has served its purpose and reached its limit. Today, Rimsys announces the Spring 2026 ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/rimsys-launches-the-regulatory-execution-engine-for-medtech\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-05T08:02:26+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20260505903088\/en\/2794344\/22\/Rimsys_name_logo%2C_full_color%2C_no_background%2C_MKT-017-A_%281%29.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rimsys-launches-the-regulatory-execution-engine-for-medtech\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rimsys-launches-the-regulatory-execution-engine-for-medtech\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Rimsys Launches the Regulatory Execution Engine for MedTech\",\"datePublished\":\"2026-05-05T08:02:26+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rimsys-launches-the-regulatory-execution-engine-for-medtech\\\/\"},\"wordCount\":985,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rimsys-launches-the-regulatory-execution-engine-for-medtech\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260505903088\\\/en\\\/2794344\\\/22\\\/Rimsys_name_logo%2C_full_color%2C_no_background%2C_MKT-017-A_%281%29.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rimsys-launches-the-regulatory-execution-engine-for-medtech\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rimsys-launches-the-regulatory-execution-engine-for-medtech\\\/\",\"name\":\"Rimsys Launches the Regulatory Execution Engine for MedTech - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rimsys-launches-the-regulatory-execution-engine-for-medtech\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rimsys-launches-the-regulatory-execution-engine-for-medtech\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260505903088\\\/en\\\/2794344\\\/22\\\/Rimsys_name_logo%2C_full_color%2C_no_background%2C_MKT-017-A_%281%29.jpg\",\"datePublished\":\"2026-05-05T08:02:26+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rimsys-launches-the-regulatory-execution-engine-for-medtech\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rimsys-launches-the-regulatory-execution-engine-for-medtech\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rimsys-launches-the-regulatory-execution-engine-for-medtech\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260505903088\\\/en\\\/2794344\\\/22\\\/Rimsys_name_logo%2C_full_color%2C_no_background%2C_MKT-017-A_%281%29.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260505903088\\\/en\\\/2794344\\\/22\\\/Rimsys_name_logo%2C_full_color%2C_no_background%2C_MKT-017-A_%281%29.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rimsys-launches-the-regulatory-execution-engine-for-medtech\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Rimsys Launches the Regulatory Execution Engine for MedTech\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Rimsys Launches the Regulatory Execution Engine for MedTech - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/rimsys-launches-the-regulatory-execution-engine-for-medtech\/","og_locale":"en_US","og_type":"article","og_title":"Rimsys Launches the Regulatory Execution Engine for MedTech - Pharma Trend","og_description":"Spring 2026 embeds submission authoring, AI-powered regulatory monitoring, and configurable impact workflows inside a single RIM platform, the first step toward Rimsys\u2019 AI vision for global regulatory operations. PITTSBURGH–(BUSINESS WIRE)–Regulatory Information Management (RIM) software was built to store records. That foundation has served its purpose and reached its limit. Today, Rimsys announces the Spring 2026 ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/rimsys-launches-the-regulatory-execution-engine-for-medtech\/","og_site_name":"Pharma Trend","article_published_time":"2026-05-05T08:02:26+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20260505903088\/en\/2794344\/22\/Rimsys_name_logo%2C_full_color%2C_no_background%2C_MKT-017-A_%281%29.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/rimsys-launches-the-regulatory-execution-engine-for-medtech\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/rimsys-launches-the-regulatory-execution-engine-for-medtech\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Rimsys Launches the Regulatory Execution Engine for MedTech","datePublished":"2026-05-05T08:02:26+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/rimsys-launches-the-regulatory-execution-engine-for-medtech\/"},"wordCount":985,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/rimsys-launches-the-regulatory-execution-engine-for-medtech\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20260505903088\/en\/2794344\/22\/Rimsys_name_logo%2C_full_color%2C_no_background%2C_MKT-017-A_%281%29.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/rimsys-launches-the-regulatory-execution-engine-for-medtech\/","url":"https:\/\/pharma-trend.com\/en\/rimsys-launches-the-regulatory-execution-engine-for-medtech\/","name":"Rimsys Launches the Regulatory Execution Engine for MedTech - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/rimsys-launches-the-regulatory-execution-engine-for-medtech\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/rimsys-launches-the-regulatory-execution-engine-for-medtech\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20260505903088\/en\/2794344\/22\/Rimsys_name_logo%2C_full_color%2C_no_background%2C_MKT-017-A_%281%29.jpg","datePublished":"2026-05-05T08:02:26+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/rimsys-launches-the-regulatory-execution-engine-for-medtech\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/rimsys-launches-the-regulatory-execution-engine-for-medtech\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/rimsys-launches-the-regulatory-execution-engine-for-medtech\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20260505903088\/en\/2794344\/22\/Rimsys_name_logo%2C_full_color%2C_no_background%2C_MKT-017-A_%281%29.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20260505903088\/en\/2794344\/22\/Rimsys_name_logo%2C_full_color%2C_no_background%2C_MKT-017-A_%281%29.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/rimsys-launches-the-regulatory-execution-engine-for-medtech\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Rimsys Launches the Regulatory Execution Engine for MedTech"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/63056","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=63056"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/63056\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=63056"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=63056"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=63056"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}